Moreover, our findings suggest that high ERp57-mediated STAT3 contributes to poor outcomes in patients with laryngeal cancer in response to radiotherapy, and targeting ERp57-STAT3 is important for enhancing the efficacy of radiotherapy. The gene discussed is STAT3; the disease is laryngeal carcinoma.